X-ray analysis of the effect of the 5-HT3 receptor antagonist granisetron on gastrointestinal motility in rats repeatedly treated with the antitumoral drug cisplatin

Association of ABCB1 Polymorphisms with the Antiemetic Efficacy of Granisetron plus Dexamethasone in Breast Cancer Patients

(2013) Daiki Tsuji et al.   Drug Metabolism and Pharmacokinetics

Molecular mechanisms of 5-HT3 and NK1 receptor antagonists in prevention of emesis

(2013) Camilo Rojas et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

P-glycoprotein ABCB1: a major player in drug handling by mammals

(2013) Piet Borst et al.   JOURNAL OF CLINICAL INVESTIGATION

Characterization of cannabinoid-induced relief of neuropathic pain in a rat model of cisplatin-induced neuropathy

(2013) Gema Vera et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Why Can’t Rodents Vomit? A Comparative Behavioral, Anatomical, and Physiological Study

(2013) Charles C. Horn et al.   PLoS One

Motilin: towards a new understanding of the gastrointestinal neuropharmacology and therapeutic use of motilin receptor agonists

(2012) G J Sanger et al.   BRITISH JOURNAL OF PHARMACOLOGY

Low molecular weight fucoidan ameliorating the chronic cisplatin-induced delayed gastrointestinal motility in rats

(2012) Moon Yong Song et al.   FOOD AND CHEMICAL TOXICOLOGY

Antiemetic efficacy of single-dose palonosetron and dexamethasone in patients receiving multiple cycles of multiple day-based chemotherapy

(2012) Vito Lorusso et al.   SUPPORTIVE CARE IN CANCER

Aprepitant plus palonosetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving multiple-day cisplatin chemotherapy

(2011) H. F. Gao et al.   INTERNAL MEDICINE JOURNAL

Solid gastric emptying mediated by the serotonin (5-HT)3 receptor in mice is a simple marker to predict emesis

(2011) Kentaro Ando et al.   JOURNAL OF TOXICOLOGICAL SCIENCES

A phase III open-label study to assess safety and efficacy of palonosetron for preventing chemotherapy-induced nausea and vomiting (CINV) in repeated cycles of emetogenic chemotherapy

(2011) Kenjiro Aogi et al.   SUPPORTIVE CARE IN CANCER

The translational value of rodent gastrointestinal functions: a cautionary tale

(2011) Gareth J. Sanger et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

The cannabinoid antagonist SR144528 enhances the acute effect of WIN 55,212-2 on gastrointestinal motility in the rat

(2010) R. Abalo et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Rikkunshito and 5-HT2C receptor antagonist improve cisplatin-induced anorexia via hypothalamic ghrelin interaction

(2010) Koji Yakabi et al.   REGULATORY PEPTIDES

Prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: Guideline update and results of the Perugia consensus conference

(2010) Fausto Roila et al.   SUPPORTIVE CARE IN CANCER

Time-course analysis of pica in rats using an automatic feeding monitoring system

(2010) Kouichi Yamamoto et al.   JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS

Acute and long-term gastrointestinal consequences of chemotherapy

(2009) Frédéric Di Fiore et al.   BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY

Opportunities for the replacement of animals in the study of nausea and vomiting

(2009) AM Holmes et al.   BRITISH JOURNAL OF PHARMACOLOGY

Evidence for a Re-Evaluation of the Neurochemical and Anatomical Bases of Chemotherapy-Induced Vomiting

(2009) Nissar A. Darmani et al.   CHEMICAL REVIEWS

Selective lack of tolerance to delayed gastric emptying after daily administration of WIN 55,212-2 in the rat

(2009) r. abalo et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Radiological study of gastrointestinal motor activity after acute cisplatin in the rat. Temporal relationship with pica

(2008) Pablo Antonio Cabezos et al.   AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL

A questionnaire study of the approach to the anorexia–cachexia syndrome in patients with cancer by staff in a district general hospital

(2008) Deepta Churm et al.   SUPPORTIVE CARE IN CANCER